$RKLB

TD Cowen reiterates Buy rating on Rocket Lab, $90 price target

TD Cowen reaffirmed a Buy rating on Rocket Lab with a $90 price target, suggesting a 52.1% upside from the Oct 14 close of $59.18. The analyst cited Rocket Lab's strong market position and long-term growth potential, despite delays in the Neutron launch.

Original reporting
Published Oct 15, 2026, 1:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 1:58 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
TD Cowen reiterates Buy rating on Rocket Lab, $90 price target — source image
Decision brief

The 30-second read

$RKLBBullishMed
01

Why it matters

The upgrade could attract new capital, supporting short‑term price gains.

02

Market read

Analyst rating change with a significant price target provides a fresh catalyst for RKLB.

03

What to watch

Potential competition from larger launch firms and funding constraints.

Relevance 7/10Novelty 7/10Timing: today

Background

TD Cowen's note highlights Rocket Lab's market position and upcoming Neutron and Photon platforms.

Company-level read

Ticker impact

$RKLBBullishHigh confidence
Context

TD Cowen reiterated a Buy rating on Rocket Lab and set a new $90 price target, implying a 52% upside from the recent close.

Expected impact

likely upward pressure as investors price in the new target

Evidence & confidence

The fresh $90 target represents a material upside and signals confidence in growth prospects.

Market effects

May boost sentiment for the small‑cap space launch sector.

Limited to U.S. investors focused on aerospace equities.

Minor, confined to Rocket Lab and comparable launch service providers.

Counterpoint

The target assumes successful Neutron launch; delays could temper upside.

Key entities

  • Rocket Lab

    U.S.-listed aerospace launch provider (ticker RKLB).

  • TD Cowen

    Equity research firm issuing the rating.

Related articles

$RKLBHigh

Rocket Lab stock tumbles as first Neutron launch slips to 2027

Rocket Lab (RKLB) shares fell 14% after announcing the first Neutron rocket launch would be delayed to 2027 due to manufacturing issues. CEO Peter Beck cited safety concerns and strong demand. Neutron is key to competing with SpaceX (SPCX) in the medium-lift rocket market. The stock is down 25% this year and 65% from its 52-week high.

$RKLBHighAI 8/10

Rocket Lab Tumbles 11% as Neutron’s First Flight Moves to 2027; SpaceX and AST SpaceMobile Pull Back

Rocket Lab's (RKLB) stock fell 11% after delaying Neutron's first flight to 2027 due to manufacturing issues. SpaceX (SPCX) and AST SpaceMobile (ASTS) also saw declines. Rocket Lab's CEO stated the problem is solved, but testing will extend into Q1 2027. The company's backlog is $2.36 billion, up 137% YoY. Investors are watching for Q3 2026 revenue guidance and test campaign progress.